# Cannabinoid-Based Interventions Autism Safety Effectiveness 2026 > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cannabinoid-based-interventions-autism-safety-effectiveness-2026/ > **Published:** 2026-05-02T12:42:01-04:00 | **Last Modified / Clinically Audited:** 2026-09-27T22:07:05-04:00 > **Clinical Summary:** Explore cannabinoid-based interventions autism safety effectiveness in this 2026 research digest covering clinical evidence and behavioral outcomes. --- CED Clinical Relevance #85 Research Authority Peer-reviewed research curated for clinical relevance and evidence quality. Recent research digest. 20 of 20 most recent studies from our monitored feeds. CED Clinical Relevance #81 Research Authority Impact of [Cannabis Edibles](https://cedclinic.com/decarboxylating-cannabis-process-why-how/) Combined With Alcohol on Driving, Field Sobriety Performance, and Subjective Effects: A Within-Participant Crossover Trial. *Zamarripa C Austin et al.* JAMA network open • 2026 IMPORTANCE: Simultaneous cannabis and alcohol use (co-use) is a public safety concern. Controlled data on the effects of co-ingestion of oral cannabis… [PubMed](https://pubmed.ncbi.nlm.nih.gov/42065887/) | [DOI](https://doi.org/10.1001/jamanetworkopen.2026.9842) CED Clinical Relevance #82 Research Authority Cannabis use and atrial arrhythmias: A systematic review and meta-analysis of large populational studies. *Chye David M et al.* Heart rhythm • 2026 BACKGROUND: Delta-9-tetrahydrocannabinol, a major component of cannabis, causes sympathetic stimulation and endothelial dysfunction. A recent American… [PubMed](https://pubmed.ncbi.nlm.nih.gov/40472951/) | [DOI](https://doi.org/10.1016/j.hrthm.2025.05.062) CED Clinical Relevance #83 Research Authority Preventing alcohol and cannabis-impaired driving among adolescents: Effects of a web-intervention in a driver education program. *Osilla Karen Chan et al.* Journal of substance use and [addiction treatment](https://cedclinic.com/cannabis-based-therapies-smoking-cessation/) • 2026 INTRODUCTION: Adolescence is a critical period during which teens initiate and escalate substance use, as well as begin learning to drive. Limited res… [PubMed](https://pubmed.ncbi.nlm.nih.gov/41850531/) | [DOI](https://doi.org/10.1016/j.josat.2026.209945) CED Clinical Relevance #84 Research Authority Cannabinoid-based interventions for behavioral outcomes in children and adolescents with autism spectrum disorder: A systematic review of safety and effectiveness. *Vasconcelos Quezia Damaris Jones Severino et al.* Progress in neuro-psychopharmacology & biological psychiatry • 2026 BACKGROUND: Autism spectrum disorder (ASD) lacks effective options for core symptoms. Cannabinoids, especially cannabidiol (CBD) and combined CBD:Δ9-t… [PubMed](https://pubmed.ncbi.nlm.nih.gov/41974303/) | [DOI](https://doi.org/10.1016/j.pnpbp.2026.111697) CED Clinical Relevance #85 Research Authority Microvascular Effects of Endocannabinoid Signaling in Sepsis: A Mechanistic and Systematic Review. *Matias Emanuel F et al.* Microcirculation (New York, N.Y. : 1994) • 2026 Microvascular dysfunction is a central determinant of organ failure in sepsis, reflecting early endothelial activation, increased permeability, and im… [PubMed](https://pubmed.ncbi.nlm.nih.gov/42068067/) | [DOI](https://doi.org/10.1111/micc.70062) CED Clinical Relevance #86 Research Authority Effects of cannabis edible advertising messages and warnings on product perceptions among US young adults. *Cui Yuxian et al.* Drug and alcohol dependence • 2026 BACKGROUND: Despite increased popularity of cannabis edibles, limited research has assessed effects of warnings or advertising emphasizing different c… [PubMed](https://pubmed.ncbi.nlm.nih.gov/42000521/) | [PMC PDF](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204451/) CED Clinical Relevance #87 Research Authority Self-reported reasons for medical and nonmedical cannabis use in Australia: A cross-sectional analysis of the International Cannabis Policy Study 2023. *Dawson Danielle et al.* Drug and alcohol dependence • 2026 INTRODUCTION: Australia’s medicinal cannabis framework has been increasingly used and commercialised. This study aimed to estimate the proportions of … [PubMed](https://pubmed.ncbi.nlm.nih.gov/41980571/) | [DOI](https://doi.org/10.1016/j.drugalcdep.2026.113124) CED Clinical Relevance #88 Research Authority The role of hopelessness and depression in cannabis-induced first-episode psychosis: a 24-month prospective study. *Ricci Valerio et al.* Addictive behaviors • 2026 Cannabis use is a recognized risk factor for psychosis, yet the psychological mechanisms mediating this relationship remain incompletely understood. T… [PubMed](https://pubmed.ncbi.nlm.nih.gov/41946034/) | [DOI](https://doi.org/10.1016/j.addbeh.2026.108699) CED Clinical Relevance #89 Research Authority The Impact of Recreational [Cannabis Legalization](https://cedclinic.com/the-forgotten-history-of-hemp-in-america/) on Cannabis Use in U.S. Adults From 2016 to 2023: A Quasi-Experimental Study. *Hawkins Summer Sherburne et al.* American journal of preventive medicine • 2026 INTRODUCTION: Although cannabis use has increased during a time of expanding cannabis legalization, there is limited evidence on how use has shifted i… [PubMed](https://pubmed.ncbi.nlm.nih.gov/41543466/) | [DOI](https://doi.org/10.1016/j.amepre.2025.108221) CED Clinical Relevance #80 Research Authority Cannabis legalization and early adolescent expectancies: Findings from the adolescent brain cognitive development study. *Ricklefs Colbey et al.* Drug and alcohol dependence • 2026 PURPOSE: Cannabis legalization in the U.S. has introduced an ongoing public health challenge. Among adults, cannabis legalization is associated with i… [PubMed](https://pubmed.ncbi.nlm.nih.gov/41895140/) | [DOI](https://doi.org/10.1016/j.drugalcdep.2026.113138) CED Clinical Relevance #81 Research Authority Social media use and health outcomes as moderated by rurality among sexual minority young adults. *Vogel Erin A et al.* The American journal on addictions • 2026 BACKGROUND AND OBJECTIVES: Social media use may influence substance use and mental health symptoms differently for urban versus rural sexual minority … [PubMed](https://pubmed.ncbi.nlm.nih.gov/40994014/) | [PMC PDF](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4055258/) | [DOI](https://doi.org/10.1186/1471-2458-14-500) CED Clinical Relevance #82 Research Authority The impact of recreational cannabis legalization on pediatric emergency department visits in British Columbia, Canada. *Xiao Melody et al.* Health promotion and chronic disease prevention in Canada: research, policy and practice • 2026 INTRODUCTION: Canadian youth report some of the highest rates of cannabis use globally, raising concerns about child and youth poisonings from uninten… [PubMed](https://pubmed.ncbi.nlm.nih.gov/41984022/) | [DOI](https://doi.org/10.24095/hpcdp.46.4.04) CED Clinical Relevance #83 Research Authority Health Care Utilization and Developmental Delay Among Infants Exposed to Cannabis In Utero. *Raffa Brittany J et al.* Academic pediatrics • 2026 OBJECTIVE: We examined the association between in utero cannabis exposure and well-child care (WCC) attendance, emergency department (ED) visits, and … [PubMed](https://pubmed.ncbi.nlm.nih.gov/41554497/) | [DOI](https://doi.org/10.1016/j.acap.2026.103224) CED Clinical Relevance #84 Research Authority The relationship between the cannabinoids and cardiac remodelling: A comprehensive review of pivotal mechanisms and emerging evidence. *Krzyżewska Anna et al.* British journal of pharmacology • 2026 Cardiac remodelling and fibrosis after myocardial infarction or during chronic diseases, such as arterial and pulmonary hypertension or diabetes melli… [PubMed](https://pubmed.ncbi.nlm.nih.gov/41662725/) | [DOI](https://doi.org/10.1111/bph.70347) CED Clinical Relevance #85 Research Authority Cannabidiol synergizes with methotrexate to attenuate rheumatoid arthritis via STAT3/NF-κB signalling-mediated M1 macrophage polarization. *Xu Jiahe et al.* International immunopharmacology • 2026 BACKGROUND: Methotrexate (MTX) is the anchor drug for rheumatoid arthritis (RA) treatment, but its clinical application is limited by dose-dependent a… [PubMed](https://pubmed.ncbi.nlm.nih.gov/41955700/) | [DOI](https://doi.org/10.1016/j.intimp.2026.116627) CED Clinical Relevance #86 Research Authority Effects of textual warnings and warning symbols on cannabis advertisements on product perceptions among US young adults. *Cui Yuxian et al.* Health education research • 2026 States with legalized non-medical cannabis require different warnings on packages and advertisements; yet, studies examining effects of textual warnin… [PubMed](https://pubmed.ncbi.nlm.nih.gov/42054015/) | [DOI](https://doi.org/10.1093/her/cyag013) CED Clinical Relevance #87 Research Authority Prepregnancy Care and Counseling: A Review. *Cooper Kylie M et al.* JAMA • 2026 IMPORTANCE: Prepregnancy care and counseling optimize [maternal health](https://cedclinic.com/recreational-cannabis-birth-outcomes-study-colorado/) before conception to improve outcomes for mothers and infants. In the US, 66.4% … [PubMed](https://pubmed.ncbi.nlm.nih.gov/42008245/) | [DOI](https://doi.org/10.1001/jama.2026.2888) CED Clinical Relevance #88 Research Authority A longitudinal DNA methylation atlas and its link to brain structure and mental health. *Chen Di et al.* Molecular psychiatry • 2026 Epigenetic mechanisms are thought to contribute to neurodevelopmental vulnerability for psychiatric disorders, yet longitudinal evidence linking DNA m… [PubMed](https://pubmed.ncbi.nlm.nih.gov/41917495/) | [PMC PDF](https://www.ncbi.nlm.nih.gov/pmc/articles/2742320/) CED Clinical Relevance #89 Research Authority Longitudinal Relationships Between Cannabis and Tobacco Use and Symptom Severity in Individuals at Clinical High Risk for Psychosis. *Bai Yunong et al.* medRxiv: the preprint server for health sciences • 2026 OBJECTIVE: Tobacco and cannabis are the most used substances among individuals at clinical high risk for psychosis (CHR-P), but it remains controversi… [PubMed](https://pubmed.ncbi.nlm.nih.gov/41929302/) | [PMC PDF](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13042115/) | [DOI](https://doi.org/10.64898/2026.03.16.26347411) CED Clinical Relevance #80 Research Authority Legalization of Cannabis Effect on Pediatric Edible Cannabis Exposures 2017-2022. *Wahl Michael et al.* Clinical pediatrics • 2026 [PubMed](https://pubmed.ncbi.nlm.nih.gov/42055917/) | [DOI](https://doi.org/10.1177/00099228261441356) Digest generated May 02, 2026 at 12:41 PM [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Cannabinoid-based interventions for behavioral outcomes in children and adolescents with autism spectrum disorder: A systematic review of safety and effectiveness.](https://cedclinic.com/cannabinoids-autism-children-systematic-review-evidence/) A detailed systematic review focusing on the safety and effectiveness of cannabinoid-based interventions in autism spectrum disorder among children and adolescents. [Read the systematic review](https://cedclinic.com/cannabinoids-autism-children-systematic-review-evidence/) [Cannabinoids for Autism: Clinical Evidence-Based Review](https://cedclinic.com/cannabinoid-clinical-trials-autism-evidence-review/) An evidence-based clinical review of cannabinoid trials targeting autism spectrum disorder, emphasizing safety and therapeutic outcomes. [Explore clinical evidence](https://cedclinic.com/cannabinoid-clinical-trials-autism-evidence-review/) [Cannabinoid-based Interventions for Behavioral Outcomes in Children and Adolescents with Autism Spectrum Disorder](https://cedclinic.com/cannabinoid-interventions-autism-spectrum-disorder/) Research insights into cannabinoid interventions addressing behavioral symptoms in autism spectrum disorder, highlighting recent clinical findings. [Discover research insights](https://cedclinic.com/cannabinoid-interventions-autism-spectrum-disorder/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=Research%20Digest%3A%2020%20Recent%20Studies%20%E2%80%93%20May%2002%2C%202026&url=https%3A%2F%2Fcedclinic.com%2Fcannabinoid-based-interventions-autism-safety-effectiveness-2026%2F) [in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2Fcannabinoid-based-interventions-autism-safety-effectiveness-2026%2F) [Share on BlueSky](https://bsky.app/intent/compose?text=Research%20Digest%3A%2020%20Recent%20Studies%20%E2%80%93%20May%2002%2C%202026%20https%3A%2F%2Fcedclinic.com%2Fcannabinoid-based-interventions-autism-safety-effectiveness-2026%2F) [Follow on Instagram](https://www.instagram.com/drbenjamincaplan) [Read more on Substack](https://doctorapprovedcannabis.substack.com/) [Subscribe via RSS](https://cedclinic.com/feed/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).